Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Courtney Grande Outlines DOJ $23 Million Settlement Related to Cardiac Devices

ABA Health Law Section


August 3, 2016

Bass, Berry & Sims attorney Courtney Grande authored an article for the American Bar Association's (ABA) Health Law Section outlining the February 2016 settlement between the U.S. government and 51 hospitals related to the improper implantation of cardiac devices. Under the terms of the settlement, hospitals must pay $23 million to settle the allegations they inappropriately billed Medicare for improperly implanting cardiac devices from 2002-2010. As Courtney states in the article, the "case is especially notable because it shows the dilemma faced by healthcare companies who misinterpret Centers for Medicare & Medicaid Services' (CMS) regulations and fail to recognize when CMS's assessment of appropriate care differs from the medical community's definition." This case serves to remind healthcare providers "to assess whether their practices comply with federal regulations, particularly as medical treatments continue to advance at a faster pace than CMS regulations."

The full article, "The New Cardiac Device Settlements: Why is it not Just the Number of Defendants that Makes this Case Notable," was published by the ABA's Health Law Section and is available online.

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.